Quantcast
Home > Quotes > ASND

Ascendis Pharma A/S American Depositary Shares (ASND) Quote & Summary Data

ASND 
$60.25
*  
3.13
4.94%
Get ASND Alerts
*Delayed - data as of Nov. 12, 2018  -  Find a broker to begin trading ASND now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
81
Today's High / Low
$ 63.78 / $ 58.12
Share Volume
149,978
50 Day Avg. Daily Volume
118,500
Previous Close
$ 63.38
52 Week High / Low
$ 76.99 / $ 33.5005
Market Cap
2,529,278,672
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -4.27
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.12

Intraday Chart

Shares Traded

Share Volume:
149,978
50 Day Avg. Daily Volume:
118,500

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -4.27

Trading Range

The current last sale of $60.25 is 79.85% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 63.78 $ 76.99
 Low: $ 58.12 $ 33.5005

Company Description (as filed with the SEC)

We were organized under the laws of the Kingdom of Denmark in September 2006 as a private limited liability company (Anpartsselskab, or ApS) and then transformed into a public limited liability company (Aktieselskab, or A/S), effective December 17, 2007. In connection with this conversion, our legal name changed from Ascendis ApS to Ascendis Pharma A/S. We commenced operations in December 2007 in connection with the acquisition of the company that invented our TransCon technology, Complex Biosystems GmbH. Our registered office and principal executive offices are located at Tuborg Boulevard 5, DK-2900Hellerup, Denmark and our telephone number is +45 70 22 22 44. Our agent for service of process in the United States is Ascendis Pharma, Inc. Our website address is www.ascendispharma.com.  ... More ...  


Risk Grade

Where does ASND fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 62.98
Open Date:
Nov. 12, 2018
Close Price:
$ 60.25
Close Date:
Nov. 12, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x